These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15588746)

  • 1. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
    Montgomery JH; Byerly M; Carmody T; Li B; Miller DR; Varghese F; Holland R
    Control Clin Trials; 2004 Dec; 25(6):598-612. PubMed ID: 15588746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.
    Heres S; Davis J; Maino K; Jetzinger E; Kissling W; Leucht S
    Am J Psychiatry; 2006 Feb; 163(2):185-94. PubMed ID: 16449469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Did CATIE influence antipsychotic use?
    Citrome L; Jaffe A; Martello D; Allingham B; Levine J
    Psychiatr Serv; 2008 May; 59(5):476. PubMed ID: 18451000
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia.
    Park T; Kuntz KM
    Value Health; 2014 Jun; 17(4):310-9. PubMed ID: 24968989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
    Kongsakon R; Leelahanaj T; Price N; Birinyi-Strachan L; Davey P
    J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial-based cost-effectiveness analyses of antipsychotic use.
    Polsky D; Doshi JA; Bauer MS; Glick HA
    Am J Psychiatry; 2006 Dec; 163(12):2047-56. PubMed ID: 17151153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What CATIE found: results from the schizophrenia trial.
    Swartz MS; Stroup TS; McEvoy JP; Davis SM; Rosenheck RA; Keefe RS; Hsiao JK; Lieberman JA
    Psychiatr Serv; 2008 May; 59(5):500-6. PubMed ID: 18451005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
    Sebastian CS; Glazer W; Buckley PF
    Curr Med Chem; 2004 Feb; 11(3):329-42. PubMed ID: 14965235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
    Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E
    J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
    Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT
    Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of side-effects of atypical antipsychotics on non-compliance, relapse and cost.
    Mortimer A; Williams P; Meddis D
    J Int Med Res; 2003; 31(3):188-96. PubMed ID: 12870371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia, VI: Treatments.
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
    Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
    J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia.
    Chen L; McCombs JS; Park J
    Value Health; 2008; 11(1):34-43. PubMed ID: 18237358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
    Kinon BJ; Liu-Seifert H; Adams DH; Citrome L
    J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
    Cipriani A; Boso M; Barbui C
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006324. PubMed ID: 19588385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
    Mohamed S; Rosenheck RA; Lin H; Swartz M; McEvoy J; Stroup S
    J Nerv Ment Dis; 2015 Jul; 203(7):486-92. PubMed ID: 26075840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Keefe RS; Bilder RM; Davis SM; Harvey PD; Palmer BW; Gold JM; Meltzer HY; Green MF; Capuano G; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Davis CE; Hsiao JK; Lieberman JA; ;
    Arch Gen Psychiatry; 2007 Jun; 64(6):633-47. PubMed ID: 17548746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.